Arkolith/Insider Trading/NKPH/Form 4

Nika Pharmaceuticals, Inc

Secretary, Director, 10% OwnerNIKA PHARMACEUTICALS, INC (NKPH) · full profile →Form 4 · filed Mar 19, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 20, 2022Other(J)145.0M—$0—
Apr 29, 2022Other(J)5.0M$50000.00$250.0B5.0M

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001826466-24-000035) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML